Provided by Tiger Fintech (Singapore) Pte. Ltd.

Co-diagnostics Inc.

0.3368
+0.00280.84%
Post-market: 0.3218-0.0150-4.45%18:00 EDT
Volume:311.86K
Turnover:109.85K
Market Cap:11.31M
PE:-0.27
High:0.3691
Open:0.3240
Low:0.3023
Close:0.3340
Loading ...

All You Need to Know About CoDiagnostics (CODX) Rating Upgrade to Buy

Zacks
·
03 Apr

Co-Diagnostics Full Year 2024 Earnings: Misses Expectations

Simply Wall St.
·
29 Mar

Co-Diagnostics Is Maintained at Neutral by HC Wainwright & Co.

Dow Jones
·
29 Mar

Q4 2024 Co-Diagnostics Inc Earnings Call

Thomson Reuters StreetEvents
·
28 Mar

Co-Diagnostics Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
28 Mar

Co-Diagnostics FY 2024 GAAP EPS $(1.24) Misses $(1.22) Estimate, Sales $3.900M Miss $4.141M Estimate

Benzinga
·
28 Mar

Press Release: Co-Diagnostics, Inc. Reports Full Year 2024 Financial Results

Dow Jones
·
28 Mar

Co-Diagnostics Inc expected to post a loss of 34 cents a share - Earnings Preview

Reuters
·
26 Mar

Co-Diagnostics Inc expected to post a loss of 34 cents a share - Earnings Preview

Reuters
·
10 Mar

Co-Diagnostics wins dismissal of class action lawsuit

TIPRANKS
·
07 Mar

Co-Diagnostics, Inc. Wins Dismissal of Class Action Lawsuit

PR Newswire
·
07 Mar

Co-Diagnostics, Inc. and CoSara to Host HPV and Cancer Symposium on International HPV Day 2025

PR Newswire
·
03 Mar

Penny Stock Co-Diagnostics Withdraws FDA Application For COVID-19 Test, Plans To Submit Enhanced Version

Benzinga
·
24 Feb

BRIEF-Co-Diagnostics Announces Intention To Submit Enhanced Version Of Covid-19 Test To FDA

Reuters
·
22 Feb

Co-Diagnostics Plans to Seek FDA Clearance for Enhanced Version of COVID-19 Test

MT Newswires Live
·
22 Feb

Co-Diagnostics Withdraws FDA Application for Covid Test

Dow Jones
·
22 Feb

Co-Diagnostics withdraws 510k application to FDA for Co-Dx PCR COVID-19 Test

TIPRANKS
·
22 Feb

Co-Diagnostics, Inc. Announces Intention to Submit Enhanced Version of Covid-19 Test to FDA for 510(K) Clearance

THOMSON REUTERS
·
22 Feb

Co-Diagnostics, Inc. Announces Intention to Submit Enhanced Version of COVID-19 Test to FDA for 510(k) Clearance

PR Newswire
·
22 Feb

Co-Diagnostics, Inc. to Exhibit at BioUtah's 2025 Life Sciences Day on the Hill

PR Newswire
·
30 Jan